Sector Charles River Laboratories International, Inc.
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
NYSE
23:00:02 28/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 291.50 USD | -1.66% |
|
-1.25% | +46.13% |
| 08-20 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 08-20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -1.66% | -1.25% | +24.24% | +61.31% | +46.13% | +78.49% | +39.02% | -34.45% | +245.95% | 13.92B | |
| -1.10% | -1.63% | +2.85% | +16.53% | +7.51% | +1.26% | +18.27% | -25.39% | +210.19% | 50.47B | |
| -6.00% | -0.75% | +8.18% | +32.00% | +160.99% | +447.48% | +524.26% | +633.26% | - | 44.56B | |
| -0.24% | +0.74% | +10.08% | +43.65% | +16.12% | +37.18% | +16.57% | +0.06% | +239.32% | 43.08B | |
| -1.55% | -2.07% | +13.86% | +27.37% | +20.71% | +19.83% | +73.63% | +21.51% | +1,153.78% | 41.7B | |
| -0.31% | -0.83% | +0.37% | +3.80% | +10.63% | +19.47% | +48.24% | -20.29% | +156.02% | 33.21B | |
| -1.79% | -3.24% | +3.86% | +34.34% | +6.94% | +26.32% | +121.63% | +225.54% | +2,055.96% | 16.77B | |
| -0.58% | -2.12% | -1.26% | +10.62% | - | - | - | - | - | 16.28B | |
| -0.47% | -1.69% | +5.66% | +16.42% | +15.42% | +10.83% | +26.71% | -40.02% | +98.18% | 14.58B | |
| +0.18% | -1.28% | +2.71% | +24.95% | -6.70% | -4.45% | -35.99% | -33.63% | +121.52% | 13.12B | |
| -9.41% | -11.90% | +44.59% | +26.89% | +8.45% | -15.58% | - | - | - | 11.56B | |
| -0.17% | +0.04% | +0.44% | +40.00% | +23.02% | +32.44% | -9.83% | -42.79% | +176.94% | 11.35B | |
| -2.93% | -8.75% | +21.58% | +74.42% | +53.99% | +44.68% | +44.68% | -49.62% | - | 10.96B | |
| -0.67% | -1.38% | -8.98% | -13.46% | -19.64% | +43.55% | +452.86% | +208.61% | +2,318.75% | 10.58B | |
| +0.01% | +0.16% | +0.50% | +64.32% | +78.82% | +271.10% | +464.73% | - | - | 10.18B | |
| -2.21% | +2.19% | +14.58% | -20.20% | -22.83% | +43.19% | +50.48% | +55.98% | +105.62% | 10.15B | |
| -1.73% | -1.38% | +10.41% | +45.11% | +51.84% | +186.77% | +503.11% | +93.31% | - | 9.82B | |
| -3.26% | +3.86% | +87.60% | +178.16% | +172.79% | +91.09% | +84.33% | -8.31% | +1,454.13% | 9.77B | |
| -6.28% | -8.30% | +12.02% | -1.49% | +16.97% | +657.03% | +1,553.48% | +20.52% | - | 9.63B | |
| -3.46% | -6.47% | +4.10% | +44.97% | +65.25% | +144.42% | +624.18% | +208.66% | +1,219.29% | 9.34B | |
| Average | -1.73% | -2.22% | +12.87% | +35.49% | +37.18% | +112.37% | +255.58% | +71.35% | +735.05% | 19.55B | |
| Weighted average by Cap. | -1.75% | -1.72% | +10.13% | +30.83% | +39.08% | +105.27% | +190.35% | +96.79% | +605.44% |
- Stock Market
- Stocks
- CRL Stock
- Sector Charles River Laboratories International, Inc.
Select your edition
All financial news and data tailored to specific country editions
